Results 41 to 50 of about 1,937,987 (265)

Immune Thrombocytopenia: A Rare Presentation of Pulmonary Sarcoidosis

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2021
Thrombocytopenia may be the initial presentation of sarcoidosis, which is a systemic granulomatous disorder. Various pathophysiological mechanisms have been identified. Immune thrombocytopenia often has a severe presentation but may respond favourably to
Mariana da Silva Leal   +5 more
doaj   +1 more source

Physician decision making in selection of second-line treatments in immune thrombocytopenia in children. [PDF]

open access: yes, 2018
Immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder which presents with isolated thrombocytopenia and risk of hemorrhage. While most children with ITP promptly recover with or without drug therapy, ITP is persistent or chronic in ...
Bennett, Carolyn M.   +23 more
core   +1 more source

COVID‐19‐associated immune thrombocytopenia

open access: yesBritish Journal of Haematology, 2020
Thrombocytopenia is a risk factor for increased morbidity and mortality in patients with the new severe acute respiratory syndrome corona virus, SARS-CoV-2 infection (COVID-19 infection).1 Thrombocytopenia in COVID-19 patients may be caused by ...
G. Bomhof   +6 more
semanticscholar   +1 more source

Normal and pathological dynamics of platelets in humans [PDF]

open access: yesJournal of Mathematical Biology volume 75, pages 1411-1462 (2017), 2016
We develop a comprehensive mathematical model of platelet, megakaryocyte, and thrombopoietin dynamics in humans. We show that there is a single stationary solution that can undergo a Hopf bifurcation, and use this information to investigate both normal and pathological platelet production, specifically cyclic thrombocytopenia.
arxiv   +1 more source

Human platelets and their capacity of binding viruses: Meaning and challenges? [PDF]

open access: yes, 2015
Blood platelets are first aimed at ensuring primary hemostasis. Beyond this role, they have been acknowledged as having functions in the maintenance of the vascular arborescence and, more recently, as being also innate immune cells, devoted notably to ...
Chabert, Adrien   +6 more
core   +2 more sources

A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia

open access: yesHaematologica, 2016
Primary immune thrombocytopenia is an autoimmune disorder in which platelet destruction is a consequence of both B- and T-cell dysregulation. Flow cytometry was used to further characterize the B- and T-cell compartments in a cross-sectional cohort of 26
Shaun M. Flint   +8 more
doaj   +1 more source

Role of thrombopoietin stimulating agents(Eltrombopag and Romiplostim) in immune thrombocytopenia secondary to SLE

open access: yesIatreia, 2021
Introduction: Immune thrombocytopenia is a frequent hematologic manifestation in systemic lupus erythematosus (SLE). Corticosteroids are the first line of treatment for moderate to severe thrombocytopenia in this disease, in conjunction with ...
Toro Vélez, Esteban   +2 more
doaj   +1 more source

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.

open access: yesBlood, 2011
Immune thrombocytopenia (ITP) is commonly encountered in clinical practice. In 1996 the American Society of Hematology published a landmark guidance paper designed to assist clinicians in the management of this disorder.
C. Neunert   +5 more
semanticscholar   +1 more source

Platelet Apoptosis in Adult Immune Thrombocytopenia: Insights into the Mechanism of Damage Triggered by Auto-antibodies [PDF]

open access: yes, 2016
Mechanisms leading to decreased platelet count in immune thrombocytopenia (ITP) are heterogeneous. This study describes increased platelet apoptosis involving loss of mitochondrial membrane potential (ΔΨm), caspase 3 activation (aCasp3) and ...
Contrufo, Geraldine   +11 more
core   +1 more source

Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia

open access: yesBlood, 2021
New treatment options are required for patients with refractory immune thrombocytopenia (ITP), a disease in which immune tolerance has been lost due to reduced regulatory T-cell (Treg) activity.
P. Han   +15 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy